News from merck kgaa A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

13 Nov, 2017, 13:15 GMT Merck Receives FDA Approval for New GONAL-f® Prefilled Pen

New pen is easy-to-learn and easy-to-use, supporting the one in six couples affected by infertility in the U.S.[1] Insights of patients, nurses and...


13 Nov, 2017, 09:15 GMT Merck and International Diabetes Federation Partner to Help Address Global Type 2 Diabetes Epidemic

The information contained in this release is not appropriate for audiences in the USA and Canada Focus on education and awareness-raising initiatives ...


11 Apr, 2016, 08:15 BST Merck Makes Pioneering Technologies Gavi, Geri and Gems Available to Fertility Clinics

Not intended for U.S. based media Merck obtains CE mark certification for consumables of Gavi™ and Geri™ as well as for the embryo culture media...


22 Feb, 2016, 16:30 GMT Merck Puts Spotlight on Women's Health and Well-being

Merck's Consumer Health business takes the lead in addressing health and well-being challenges of women around the world Experts worldwide join a...


03 Feb, 2016, 08:15 GMT Merck Set to Launch New Version of Fertility Pens

The Fertility Leader Merck receives market authorization from EMA for its advanced GONAL-f® prefilled pen for improved ease-of-use Patients, nurses...


12 May, 2015, 11:25 BST Merck Receives FDA Fast Track Designation for Evofosfamide for Treatment of Patients Living With Advanced Pancreatic Cancer

- NOT INTENDED FOR US AND UK BASED MEDIA - Evofosfamide is an investigational compound currently in Phase III trials Advanced pancreatic cancer is...


12 Sep, 2014, 15:06 BST Merck Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer

Not intended for UK-based media Merck announced today that its biopharmaceutical division Merck Serono will discontinue the clinical development...


01 Jun, 2014, 00:30 BST Merck to Collaborate with Sysmex Inostics on a Blood-Based RAS Biomarker Test

Development and commercialization agreement on blood-based RAS biomarker mutation status test for (metastatic) colorectal cancer (mCRC) This...


15 May, 2014, 09:50 BST Merck Announces New Retrospective Analysis Shows Significant Clinical Benefit in Overall Survival for Metastatic Colorectal Cancer Patients with RAS Wild-Type Tumors Receiving Erbitux plus FOLFIRI

ASCO Abstract Number: 3506 In a retrospective analysis of the Phase III CRYSTAL* study, which assessed RAS tumor status, significant clinical benefit ...


24 Apr, 2014, 07:30 BST Merck Announces Positive Outcome of IIIb Study for Kuvan

Primary endpoint met in SPARK study: significant increase in phenylalanine tolerance demonstrated after 26 weeks of the study in children less than 4 ...


27 Mar, 2014, 07:20 GMT Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients

 The ESPART* Phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation Study aims to recruit 946 patients...